Trials / Completed
CompletedNCT04285489
A Study on the Safety of Hakim Programmable Shunt System
A Multi-center, Retrospective Registry Study on the Safety of Hakim Programmable Shunt System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 130 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 2 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to collect safety information from subjects implanted with a shunt system (trade name: Hakim Shunt Programmable System) produced by Codman \& Shurtleff, Inc. of the United States. Device safety would be assessed based on all the adverse events that occurred within one year after the subjects implanted the catheter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hakim Shunt Programmable System | patient accept Hakim Shunt Programmable System due to HCP |
Timeline
- Start date
- 2020-05-02
- Primary completion
- 2020-07-28
- Completion
- 2020-07-28
- First posted
- 2020-02-26
- Last updated
- 2021-11-05
- Results posted
- 2021-09-21
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04285489. Inclusion in this directory is not an endorsement.